Bloomberg Businessweek cover image

Bloomberg Businessweek

Bristol’s $14 Billion Karuna Deal Highlights Race for New Drugs

Dec 22, 2023
Bristol Myers' $14 billion acquisition of Karuna Therapeutics in the race for new drugs. Finding value in the markets explained by CIO at NFJ Investment Group. Priceline CEO talks about a busy holiday travel season. Year in crypto and outlook for 2024. Silicon Valley's quest to live forever. Insights on stock market, investment strategies, and video industry. Travel industry updates and currency market analysis.
01:02:10

Podcast summary created with Snipd AI

Quick takeaways

  • Silicon Valley is divided between those who believe in living forever and those who focus on extending healthy life through conservative approaches and FDA-approved treatments.
  • The pursuit of longevity highlights clashes between philosophical aspirations and practical advancements, as well as concerns about accessibility and equality in accessing anti-aging treatments.

Deep dives

The Quest for Immortality in Silicon Valley

Silicon Valley has a unique obsession with anti-aging and longevity, with some individuals and groups actively promoting the idea of immortality. Anti-death activism and immortalist views are driving a belief that death from aging is a bad thing and should be eliminated. However, there is significant debate within the longevity field, with some researchers focusing on more conservative approaches and FDA-approved treatments to extend healthy life rather than seeking to live forever. While advancements in anti-aging and longevity are being made, accessibility and equality in accessing these treatments remain concerns.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner